[Scleroderma: Pathogenesis, pathophysiology, and therapy]

Nihon Rinsho. 2006 Feb:64 Suppl 2:446-9.

[Article in Japanese]

Authors

Hirokazu Imai¹, Keisuke Suzuki

Affiliation

¹ Division of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University School of Medicine.

PMID: 16523931

No abstract available

Publication types

Review

MeSH terms

Acute Kidney Injury / etiology*
Acute Kidney Injury / pathology
Acute Kidney Injury / physiopathology
Acute Kidney Injury / therapy
Epoprostenol / administration & dosage
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents / therapeutic use
Kidney / pathology
Prognosis
Prostaglandins E / administration & dosage
Scleroderma, Systemic* / etiology
Scleroderma, Systemic* / pathology
Scleroderma, Systemic* / physiopathology
Scleroderma, Systemic* / therapy
Transplantation, Autologous

Substances

Immunosuppressive Agents
Prostaglandins E
Epoprostenol